Table 4.
Health care use by phase, assessment, and group.
| Resource | Baseline | FUP1a | FUP2b |
|
|
||||||||||||||||
|
|
Intervention | Control | Intervention | Control | Intervention | Control |
|
|
|||||||||||||
| Treatment |
|
||||||||||||||||||||
|
|
Last seen PCPc, n (%) | ||||||||||||||||||||
|
|
|
1-2 weeks ago | 7 (21) | 3 (9) | 5 (15) | 4 (13) | 3 (9) | 8 (25) |
|
|
|||||||||||
|
|
|
3-4 weeks ago | 5 (15) | 4 (13) | 7 (21) | 1 (3) | 5 (15) | 3 (9) |
|
|
|||||||||||
|
|
|
>4 weeks agod,e,f | 21 (64) | 25 (78) | 21 (64) | 27 (84) | 20 (61) | 21 (66) |
|
|
|||||||||||
|
|
|
Missing | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 5 (15) | 0 (0) |
|
|
|||||||||||
| Reason for last visit to the PCP, n (%) |
|
||||||||||||||||||||
|
|
|
General checkup | 6 (18) | 9 (28) | 6 (18) | 8 (25) | 7 (21) | 9 (28) |
|
|
|||||||||||
|
|
|
Discuss symptoms that may be related to my cancer | 5 (15) | 6 (19) | 2 (6) | 2 (6) | 5 (15) | 1 (3) |
|
|
|||||||||||
|
|
|
Discuss cancer treatment | 7 (21) | 3 (9) | 6 (18) | 6 (19) | 7 (21) | 7 (22) |
|
|
|||||||||||
|
|
|
Discuss another medical concern | 8 (24) | 9 (28) | 12 (36) | 8 (25) | 7 (21) | 10 (31) |
|
|
|||||||||||
|
|
|
Other | 13 (39) | 9 (28) | 12 (36) | 11 (34) | 12 (36) | 9 (28) |
|
|
|||||||||||
| Survivorship |
|
|
|||||||||||||||||||
|
|
Last seen PCP, n (%) |
|
|||||||||||||||||||
|
|
|
1-2 weeks ago | 9 (21) | 7 (14) | 7 (16) | 12 (23) | 6 (14) | 6 (12) |
|
|
|||||||||||
|
|
|
3-4 weeks ago | 8 (19) | 2 (4) | 8 (19) | 8 (15) | 10 (23) | 12 (23) |
|
|
|||||||||||
|
|
|
>4 weeks agod | 26 (60) | 43 (83) | 28 (65) | 28 (54) | 27 (63) | 31 (60) |
|
|
|||||||||||
|
|
|
Missing | 0 (0) | 0 (0) | 0 (0) | 4 (8) | 0 (0) | 3 (6) |
|
|
|||||||||||
|
|
Reason for last visit to the PCP, n (%) |
|
|||||||||||||||||||
|
|
|
General checkup | 10 (23) | 14 (27) | 11 (26) | 17 (33) | 18 (42) | 24 (46) |
|
|
|||||||||||
|
|
|
Discuss symptoms that may be related to my cancer | 5 (12) | 6 (12) | 1 (2) | 1 (2) | 5 (12) | 1 (2) |
|
|
|||||||||||
|
|
|
Discuss cancer survivorship | 2 (5) | 3 (6) | 8 (19) | 5 (10) | 1 (2) | 3 (6) |
|
|
|||||||||||
|
|
|
Discuss another medical concern | 19 (44) | 23 (44) | 18 (42) | 22 (42) | 12 (28) | 14 (27) |
|
|
|||||||||||
|
|
|
Other | 11 (26) | 11 (21) | 15 (35) | 13 (25) | 12 (28) | 13 (25) |
|
|
|||||||||||
aFUP1: first follow-up.
bFUP2: second follow-up.
cPCP: primary care provider.
dThe baseline questionnaire included more response options than the follow-up questionnaire (1-3 months ago, 4-6 months ago, and >6 months ago), which had collapsed into the >4 weeks ago category.
eAt baseline in the intervention group for the treatment phase, 12 patients (36%) indicated 1 to 3 months ago, 5 patients (15%) indicated 4 to 6 months ago, and 4 patients (12%) indicated more than 6 months ago. At baseline in the control group for the treatment phase, 18 patients (56%) indicated 1 to 3 months ago, 5 patients (16%) indicated 4 to 6 months ago, and 2 patients (6%) indicated more than 6 months ago.
fAt baseline in the intervention group for the survivorship phase, 12 patients (28%) indicated 1 to 3 months ago, 10 patients (23%) indicated 4 to 6 months ago, and 4 patients (9%) indicated more than 6 months ago. At baseline in the control group for the survivorship phase, 26 patients (50%) indicated 1 to 3 months ago, 13 patients (25%) indicated 4 to 6 months ago, and 4 patients (8%) indicated more than 6 months ago.